3.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie
VistaGen Therapeutics (NASDAQ:VTGN) Rating Increased to Hold at Wall Street Zen - MarketBeat
Can Vistagen Therapeutics Inc. Bounce Back From Weekly Low2025 Geopolitical Influence & Long Hold Capital Preservation Tips - Newser
Is now a turning point for Vistagen Therapeutics Inc.Weekly Earnings Recap & AI Enhanced Trading Signals - Newser
Analyzing recovery setups for Vistagen Therapeutics Inc. investorsEarnings Trend Report & Weekly High Return Forecasts - Newser
What to do if you’re stuck in Vistagen Therapeutics Inc.Portfolio Value Report & Stock Portfolio Risk Control - Newser
Vistagen Therapeutics Inc.’s volatility index tracking explained2025 Trade Ideas & Accurate Buy Signal Notifications - Newser
Earnings visualization tools for Vistagen Therapeutics Inc.Market Volume Report & Accurate Intraday Trade Tips - Newser
Volatility clustering patterns for Vistagen Therapeutics Inc.2025 Winners & Losers & Weekly Setup with High ROI Potential - Newser
How to build a custom watchlist for Vistagen Therapeutics Inc.Weekly Gains Summary & Verified Entry Point Signals - Newser
Using AI based signals to follow Vistagen Therapeutics Inc.Market Sentiment Report & Weekly Top Performers Watchlists - Newser
Can trapped investors hope for a rebound in Vistagen Therapeutics Inc.Bull Run & Technical Entry and Exit Alerts - Newser
How to interpret RSI for Vistagen Therapeutics Inc. stockShare Buyback & Stock Portfolio Risk Management - Newser
Using Python tools to backtest Vistagen Therapeutics Inc. strategiesWeekly Profit Summary & Verified Entry Point Signals - Newser
What candlestick patterns are forming on Vistagen Therapeutics Inc.GDP Growth & Safe Entry Trade Reports - Newser
Heatmap analysis for Vistagen Therapeutics Inc. and competitorsTrade Exit Report & Comprehensive Market Scan Insights - Newser
Vistagen Therapeutics Inc. stock outlook for YEAREarnings Growth Report & Community Verified Swing Trade Signals - Newser
Intraday pattern recognizer results for Vistagen Therapeutics Inc.Weekly Loss Report & High Return Stock Watch Alerts - Newser
Will Vistagen Therapeutics Inc. see short term momentum2025 Analyst Calls & Trade Opportunity Analysis Reports - Newser
Why Vistagen Therapeutics Inc. stock attracts strong analyst attentionExit Point & Expert Approved Momentum Ideas - Newser
How to track smart money flows in Vistagen Therapeutics Inc.Portfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Is Vistagen Therapeutics Inc. trending in predictive chart modelsWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Retail Investors Hold Significant Control Over Vistagen Therapeutics, Inc. - AInvest
retail investors who own 49% along with institutions invested in Vistagen Therapeutics, Inc. (NASDAQ:VTGN) saw increase in their holdings value last week - simplywall.st
Technical analysis overview for Vistagen Therapeutics Inc. stockJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Using R and stats models for Vistagen Therapeutics Inc. forecastingAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - Newser
Evaluating Vistagen Therapeutics Inc. with trendline analysisWeekly Trade Review & Fast Moving Stock Trade Plans - Newser
Is Vistagen Therapeutics Inc. stock a good hedge against inflationJuly 2025 Highlights & Real-Time Market Sentiment Alerts - Newser
Vistagen Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks
What makes Vistagen Therapeutics Inc. stock attractive to long term investorsRate Cut & Verified Momentum Watchlists - Newser
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q1 2026 Earnings Call Transcript - MSN
Vistagen Therapeutics Inc. Q1 Earnings Call Highlights: Progress Amid Challenges and Financial Pressures. - AInvest
VistaGen Therapeutics (NASDAQ:VTGN) Posts Quarterly Earnings Results - MarketBeat
Vistagen (VTGN) Q1 R&D Expense Jumps 54% - AOL.com
Published on: 2025-08-12 05:18:03 - Newser
Is Vistagen Therapeutics Inc. stock a good dividend stockGame-Changing Investment Alerts - thegnnews.com
VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Misses Revenue Estimates - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):